conclusions
Last reviewed 01/2018
The conclusions of the trial are:
- hypertension is a strong risk factor for the development of type II diabetes mellitus
- only beta-blockers among the commonly used anti-hypertensive medications are associated with an increased risk of developing type II diabetes mellitus
- when deciding whether to give a beta-blocker the increased risk of developing type II diabetes should be weighed against the proven cardiovascular benefits of beta-blockade
- concerns about diabetes should not discourage the prescription of thiazide diuretics